Monoclonal Antibodies Marketplace Returning Consistent Profit as Awareness Regarding Cancer Grows
Sep 4, 2019
The global monoclonal antibodies market size valued at $101 billion and the growth is expected to propel at a CAGR of 8.5%, during the forecast period 2019-2025.
Hyderabad, India - September 4, 2019 /MarketersMedia/ —
Technology is one of the greatest invention of mankind and has gifted human beings with various boons. But with the advent of time technological advancement emerged as a great threat to human civilization. Technology provides wide benefits —catching serial killers, space exploration, diagnosing cancer, — but algorithms designed for one intention can be easily used for a direful one. For instance, gene editing technology called CRISPR (Clustered, Regularly Interspaced, Short Palindromic Repeat) is a breakthrough in healthcare industry, though it is commendable, it is feared that its deliberate or unintentional misuse might lead to far-reaching economic and national security implications. One of the major threats emerged with the introduction of CRISPR is the production of biological weapons. The ease of accessibility of this technology made bioweapons extremely cheaper as compared to missiles or other hi-tech warfare equipment. Considering the harmful impacts of bioweapons, governments across the world are investing in R&D activities to seek out methods to acknowledge diseases released by biological weapons such as smallpox, plague, cholera, and anthrax. Antibody vaccines effectively induce the desired medication with comparatively higher rates of success, leading to development of monoclonal antibodies (mAbs), which target a specific area or cell.
Monoclonal antibodies (mAbs) are designed by hybridoma technology with an aim to trigger natural immune system. It is a flagship innovation in the molecular biology approved by the U.S. Food and Drug Administration (FDA) as an effective measure for disease treatment. In 2018, the global monoclonal antibodies market size valued at $101 billion and the growth is expected to propel at a CAGR of 8.5%, during the forecast period 2019-2025. The report covers Monoclonal Antibodies Market size by type and applications, Monoclonal Antibodies Market share by top 5 companies and also the market share by start-ups during the forecast period.
View Full Table of Contents of Monoclonal Antibodies Market:
https://www.industryarc.com/Report/16114/monoclonal-antibodies-market.html
Report Price (Single User): US $3850
Oncology Segment dominating the Monoclonal Antibodies Market Growth—
The growth in monoclonal antibodies market size is attributed to various factors such as increasing demand for antibodies to treat several health issues like respiratory diseases, oncology, autoimmune diseases, microbial diseases, inflammatory diseases, and ophthalmology disorders. Oncology segment is expected to generate major revenue in the monoclonal antibodies market, the key application segment is poised to propel at a CAGR of 8.67% through to 2025, owing to increasing incidences of cancer. Cancer is one of the leading causes of death worldwide, which has driven the focus on early detection and treatment of disease. According to Cancer Research UK, there were around 17 million new cases of cancer in 2018, and 9.6 million deaths worldwide in 2018. The monoclonal antibodies cancer treatment stimulate the immune system to attack and destroy diseased cells. The monoclonal antibodies therapy adhere themselves to cancer cells, facilitating a simpler way for immune cells to spot diseased cells.
Multifarious Applications of Monoclonal Antibodies—
The significant role of mAbs in organ transplantations, analyzing bodily fluids for diagnosis, cardiovascular detection, and diagnosis of infectious diseases agents like HIV, and cause of AIDS are supporting the market growth. Additionally mAbs are eminent components in home-testing kits for determining ovulation, pregnancy, and menopause. They are also used to detect viruses in plants and animals; and in environmental pollution monitoring. Moreover, prominent benefits associated with monoclonal antibodies is that they can be developed in low investment and on a large-scale. Thus, these factors are expected to create burgeoning demand of monoclonal antibodies.
Major developments in Monoclonal Antibodies Market—
· On 20 September 2017, Nivolumab (Opdivo) a monoclonal antibody drug, was made available for NHS patients with advanced lung cancer.
· A 33-year old man suffering from schizophrenia is the first person treated by using monoclonal antibody drug at King’s College Hospital in London on 3 November 2017.
· On 20 September 2017, an amalgamation of three monoclonal antibodies was developed which is intended to protect monkeys from HIV.
Monoclonal Antibodies Market Leveraging Europe Region—
Europe held major share in the global monoclonal antibiotics market, accounting to 42.3% in 2018. This is mainly attributed to high incidence rate of cancer in this region. According to the World Health Organization (WHO), there are more than 3.7 million new cancer cases and 1.9 million deaths each year. Cancer represents as the second most cause of death and morbidity in Europe. Additionally, increasing R&D activities to introduce advanced production methods for mAbs in countries such as the Netherlands, Switzerland, Denmark, Germany, and others is significantly contributing to growth of the European market. Growing consumer awareness about various benefits and applications of mAb including detecting and killing abnormal cells directly, delivering radioactive particles or chemo drugs to specific cells, thereby minimizing the risk of side-effects from medication while also triggering the immune system, is also a major driving factor for the market growth. Moreover, presence of major pharmaceuticals companies such as GlaxoSmithKline plc, Novartis AG, and F. Hoffmann-La Roche Ltd. have rendered Europe with the maximum market share.
Talk to one of our sales representative about the full report by providing your details in the link below:
https://www.industryarc.com/support.php?id=16114
Monoclonal Antibodies Market Company Strategies—
Major companies striving to mark their presence in the global monoclonal antibodies market include Pfizer, Inc., Merck & Co., Inc., Amgen, Inc., GlaxoSmithKline plc, Abbott Laboratories, AstraZeneca, Novartis AG, Eli Lilly and Company, Mylan N.V., Bayer AG, Bristol Myers Squibb Co., Daiichi Sankyo Company, Ltd., Biogen Inc., Thermo Fisher Scientific, Inc., Johnson & Johnson Services, Inc., F. Hoffmann-La Roche Ltd., Novo Nordisk A/S, Sanofi Genzyme, and others. These companies are focusing on investing in R&D activities to innovate different monoclonal antibodies to treat various diseases.
· In July 2019, GlaxoSmithKline plc announced the UK trial of subscription-style payment system for pharmaceutical companies to emerge in the development of new antibiotics. It also announced the start of Phase 3 program for the development of anti GM-CSF monoclonal antibody for the treatment of moderate to severe rheumatoid arthritis (RA).
· In 2018, Thermo Fisher Scientific entered in collaboration with Symphogen, an antibody development company for two years. With this tie-up Symphogen is instigated to use liquid chromatography-tandem mass spectrometry system of Thermo Scientific to develop, inspect and confirm the platform workflows for mass analysis of therapeutic monoclonal antibody mixtures.
Related Reports:
a) Antibody Production Market
https://www.industryarc.com/Research/Antibody-Production-Market-Research-504143
b) Biosimilar Monoclonal Antibody Market
https://www.industryarc.com/Research/Biosimilar-Monoclonal-Antibody-Market-Research-501907
About IndustryARC:
IndustryARC primarily focuses on Cutting Edge Technologies and Newer Applications market research. Our Custom Research Services are designed to provide insights on the constant flux in the global supply-demand gap of markets. Our strong team of analysts enables us to meet the client research needs at a rapid speed, with a variety of options for your business. Any other custom requirements can be discussed with our team, drop an e-mail to [email protected] to discuss more about our consulting services.
Contact Info:
Name: Venkat Reddy
Email: Send Email
Organization: IndustryARC
Phone: (+1) 614-588-8538
Website: https://www.industryarc.com/Domain/8/lifesciences-healthcare-market-research.html
Source: MarketersMedia
Release ID: 88913760
More News
Microsoft pulls out of UK's largest AI data centre
Tech firm Nscale says it is still committed to building the site in Essex.
Ulanqab steps up building green computing hub
Ulanqab steps up building green computing hub
Oklahoma Families Faced the Hottest Summer Ever and an Electricity Crisis
Record heat and a rising demand for electricity are closing in on Oklahoma families trying to keep the lights on and the AC running.
Global AI governance initiative charts a fairer way to share AI value
Today, AI value is concentrated in a few closed-source giants, and platform companies collect high rents by controlling ecosystem gateways. The Chinese approach instead supports a thriving open source ecosystem.
Gleaning group gives £1m of produce to food banks
Gleaning Cornwall warns that more funding is needed as costs rise sharply.
What is the Budget and what could be in it?
Chancellor John Healey will set out his plans for UK taxes on 28 October.
PBOC: Need reforms, not exchange rates, to address global imbalances
Discussions over the renminbi's exchange rate has intensified as global economic imbalances widen. An International Monetary Fund policy paper published in April said imbalances had widened again after more than a decade of decline. Against this backdrop, the People's Bank of China, China's central bank, issued a detailed statement on October 8 setting out its position on the RMB exchange rate.
China's property recovery gains traction as new policies take effect
China has rolled out a raft of new property policies over the past two months covering the home-sales system, mortgage interest subsidies, and housing provident fund rules, aiming to reduce the sector's high leverage and unlock housing demand.
3 Charts That Explain the Economy as Voters Head to the Polls
Inflation is high, consumer spending is strong and seemingly everything depends on what happens with artificial intelligence.
United’s C.E.O. Says It Should Cost More Not to Sit in the Middle Seat
Scott Kirby of United Airlines said that “it’s expensive to fly airplanes” and that airfares may have further to rise.
Turning the tides: Could hidden sea power energise our coastal towns?
Engineer David Mummery has developed a tidal energy generator that he says can change lives for people living in coastal communities.
'I took a chance on the whisky industry and I haven't looked back'
Zoey Darnbrough had no idea there was a distillery near her home - now she has a top tourism role there.
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.